Opportunity Information: Apply for PAR 21 331

The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), is soliciting investigator-initiated research applications under the R01 mechanism for studies that explain how bariatric surgery may change a persons risk of developing cancer. The central aim of this opportunity is to push the field beyond the more commonly studied short-term outcomes of bariatric procedures, such as weight loss or improvements in diabetes, and instead focus on the biological, behavioral, and clinical mechanisms that could plausibly increase or decrease cancer risk after surgery. The announcement is titled "Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)" and is listed as PAR-21-331. Because it is "clinical trial optional," applicants can propose projects that are purely mechanistic and observational, or projects that include a clinical trial component if it is scientifically justified, but a clinical trial is not required.

Projects supported through this FOA are expected to center on mechanistic questions that connect bariatric surgery to cancer-related pathways and outcomes. In practical terms, that means studies designed to clarify what changes after surgery (for example, metabolic hormones, inflammation, immune function, bile acid signaling, gut microbiome alterations, nutrient absorption, tissue-specific changes, or other physiological shifts) and how those changes could influence cancer initiation, progression, or prevention. The FOA also signals that NCI is interested in attracting researchers who already work in bariatric surgery and related fields to apply their expertise to cancer-focused endpoints, risk markers, and longer-term cancer-relevant follow-up, rather than stopping at intermediate endpoints like pounds lost or glycemic control.

The funding instrument is a discretionary federal grant using the NIH R01 activity code, which generally supports substantial, multi-year research projects led by independent investigators. The opportunity is categorized under education and health-related federal assistance and is associated with CFDA numbers 93.393, 93.396, and 93.399, reflecting its placement within NIH/NCI assistance listings. The posted award ceiling in the provided source data is $500,000, indicating a maximum level stated for this opportunity in the summary information. The original closing date shown is 2024-09-07, which functions as the application due date reference in the provided listing.

A wide range of applicant organizations are eligible. This includes state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits (both 501(c)(3) and non-501(c)(3), excluding higher education institutions when specified); for-profit organizations other than small businesses; and small businesses. The FOA also explicitly highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, Indian/Native American tribal governments other than federally recognized entities, and U.S. territories or possessions.

At the same time, the FOA sets clear limits on foreign participation. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply as the primary applicant organization, and non-domestic components of U.S. organizations are also not eligible to apply. However, foreign components are allowed as defined in the NIH Grants Policy Statement, which generally means a U.S.-based applicant can include certain collaborations, performance sites, or project components outside the United States when they are well-justified and compliant with NIH policy. This structure preserves U.S. applicant leadership while still permitting scientifically necessary international elements.

Overall, this grant opportunity is meant for research teams that can rigorously investigate why bariatric surgery might alter cancer risk, identify the pathways responsible, and generate evidence that helps connect a major clinical intervention to cancer prevention biology and outcomes. It is positioned to support deeper, mechanism-driven work that can inform future cancer risk stratification, surveillance strategies, and potentially intervention design for patients undergoing bariatric surgery.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393, 93.396, 93.399.
  • This funding opportunity was created on 2021-09-03.
  • Applicants must submit their applications by 2024-09-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $500,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 21 331

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Early Career Research Program

Previous opportunity: Guinea Local Health System Strengthening Activity (LHSSA)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 21 331

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 21 331) also looked into and applied for these:

Funding Opportunity
High Priority HIV and Substance Use Research (R01 Clinical Trial Optional) Apply for RFA DA 22 040

Funding Number: RFA DA 22 040
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Pharmacokinetics (PK) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R01 - Clinical Trial Optional) Apply for RFA DA 22 028

Funding Number: RFA DA 22 028
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Pharmacokinetics (PK) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R21 - Clinical Trial Optional) Apply for RFA DA 22 039

Funding Number: RFA DA 22 039
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) Apply for PAR 21 330

Funding Number: PAR 21 330
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) Apply for PAR 21 302

Funding Number: PAR 21 302
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed) Apply for PAR 21 301

Funding Number: PAR 21 301
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional) Apply for PAS 21 270

Funding Number: PAS 21 270
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,000,000
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Independent Clinical Trial Not Allowed) Apply for PAR 21 300

Funding Number: PAR 21 300
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required) Apply for PAR 21 299

Funding Number: PAR 21 299
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed) Apply for PAR 21 335

Funding Number: PAR 21 335
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional) Apply for PAR 21 334

Funding Number: PAR 21 334
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $600,000
NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed) Apply for PAR 21 333

Funding Number: PAR 21 333
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $600,000
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) Apply for RFA CA 21 059

Funding Number: RFA CA 21 059
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) Apply for PAR 21 329

Funding Number: PAR 21 329
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HEAL initiative: Pharmacotherapies to Reverse Opioid Overdose Induced Respiratory Depression Without Central Opioid Withdrawal (Target Validation and Candidate Therapeutic Development) (UG3/UH3 Clinical Trials Not Allowed) Apply for RFA HL 22 013

Funding Number: RFA HL 22 013
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional) Apply for PAR 21 348

Funding Number: PAR 21 348
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Limited Competition: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed) Apply for PAR 21 346

Funding Number: PAR 21 346
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $940,000
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) Apply for PAR 21 341

Funding Number: PAR 21 341
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIH Health Care Systems Research Collaboratory - Pragmatic and Implementation Trials of Embedded Interventions (UG3/UH3, Clinical Trials Optional) Apply for RFA AT 22 001

Funding Number: RFA AT 22 001
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Clinical Research Education and Career Development (CRECD) Program (R25-Independent Clinical Trial Not Allowed) Apply for PAR 21 347

Funding Number: PAR 21 347
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 21 331", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: